Aarti Drugs to hold analyst meet on June 23 in Tarapur

0 min read Updated on 17 Jun 2026, 12:36 AM

Reviewed by

Ashish TScanX News Team

AI Summary

Aarti Drugs has scheduled a group meeting for analysts and institutional investors on June 23, 2026, in Tarapur, Maharashtra, from 10:00 AM to 3:30 PM. The company confirmed that discussions will rely solely on publicly available information and no unpublished price sensitive information (UPSI) will be shared. The disclosure was made under Regulation 30(6) of the SEBI (LODR) Regulations, 2015.

*this image is generated using AI for illustrative purposes only.

Aarti Drugs will host a group meeting for analysts and institutional investors on June 23, 2026, at Tarapur, Maharashtra. The meeting is scheduled to take place between 10:00 AM and 3:30 PM. The company stated that discussions during the interaction will be based solely on publicly available information.

The disclosure was made pursuant to Regulation 30(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. Aarti Drugs clarified that no unpublished price sensitive information (UPSI) is intended to be shared during the proceedings.

The schedule for the meeting is detailed below:

Date & Time	Nature of Meeting	Venue
23 June 2026 10:00 AM to 3:30 PM	Group Meeting	Tarapur, Maharashtra

Rushikesh Deole, Company Secretary & Compliance Officer, signed the intimation sent to the stock exchanges. The company noted that changes to the schedule may occur due to exigencies on the part of the host or the company.

Historical Stock Returns for Aarti Drugs

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
-0.76%	+0.31%	-4.49%	-9.68%	-13.96%	-47.63%

What strategic growth initiatives does Aarti Drugs plan to highlight during the meeting?

How might the company's recent performance influence investor sentiment post-meeting?

What are the potential market reactions to any updates on regulatory compliance or operational challenges?

Read Next Article

Aarti Drugs to hold virtual investor meeting on June 10

1 min read Updated on 05 Jun 2026, 01:15 PM

Reviewed by

Ashish TScanX News Team

Add as a preferred
source on Google

AI Summary

Aarti Drugs Limited will conduct a virtual analyst and institutional investor meeting on June 10, 2026, organized by Choice Institutional Equities. The company confirmed that no unpublished price sensitive information will be discussed. The disclosure was made in compliance with Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

*this image is generated using AI for illustrative purposes only.

Aarti Drugs Limited has scheduled a virtual meeting with analysts and institutional investors for June 10, 2026. The session will take place between 12:00 PM and 1:00 PM and is organized by Choice Institutional Equities. The company stated that discussions will be based solely on publicly available information and no unpublished price sensitive information (UPSI) will be shared.

The meeting is being held pursuant to Regulation 30(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015. This regulation mandates the disclosure of such investor interactions to ensure transparency.

The following table outlines the details of the scheduled meeting:

Date & Time	Nature of Meeting	Organised by	Venue
10 June 2026 12:00 PM to 1:00 PM	Group Meeting	Choice Institutional Equities	Virtual

Rushikesh Deole, Company Secretary & Compliance Officer of Aarti Drugs Limited, signed the intimation submitted to the stock exchanges on June 05, 2026. The company noted that changes to the schedule may occur due to exigencies on the part of the host or the company.

Aarti Drugs Limited is a manufacturer of bulk drugs and chemicals, headquartered in Mumbai. The intimation was addressed to the Listing and Compliance Departments of both BSE Limited and the National Stock Exchange of India Limited.

Historical Stock Returns for Aarti Drugs